Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Castle Biosciences, Inc. Common Stock (CSTL) has a market cap of $738.31M with year-over-year revenue growth of +51.1%. Net margin stands at 5.5%. The stock trades at a P/E ratio of 40.5.
Compared to other companies in the SERVICES-MEDICAL LABORATORIES sector, CSTL posted revenue growth of +51.1% and trades at a P/E of 40.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.